ImmunoGenesis Announces Two Publications Highlighting the Potential of IMGS-203, a Novel Stimulator of Interferon Genes (STING) Agonist, to
HOUSTON, Nov. 5, 2026 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing inn
Related stories
UPDATE 6-Largely peaceful marches take place across France as workers stage strike
UPDATE 6-Largely peaceful marches take place across France as workers stage strike Adds crowd size e
L impact | EQUITY | Nov 05, 2026, 05:25 PM UTC
Form 487 FT 13339
Filed on: November 5, 20
L impact | EQUITY | Nov 05, 2026, 05:25 PM UTC
Form F-6EF Chervon Holdings Ltd/ADR Filed by: Citibank,N.A./ADR
Filed on: November 5, 20
L impact | EQUITY | Nov 05, 2026, 05:25 PM UTC
Tech selloff, defence weakness weigh on European shares
Tech selloff, defence weakness weigh on European shares Updates after markets close STOXX 600 falls
L impact | EQUITY | Nov 05, 2026, 05:24 PM UTC
Es la tercera en casi ocho meses: aterriza nueva jefa de gabinete de Poduje desde Presidencia
Es la tercera en casi ocho meses: aterriza nueva jefa de gabinete de Poduje desde Presidencia Este m
L impact | EQUITY | Nov 05, 2026, 05:24 PM UTC
L.B. Foster Acquires Dulworth for USD 52.2 Million, Adding USD 18 Million Revenue Business
M impact | EQUITY | Nov 05, 2026, 05:24 PM UTC